RBC Capital Reiterates Sector Perform on SolarWinds, Maintains $11 Price Target
RBC Capital analyst Matthew Hedberg reiterates SolarWinds (NYSE:SWI) with a Sector Perform and maintains $11 price target.
RBC Capital Reiterates Outperform on S&P Global, Maintains $434 Price Target
RBC Capital analyst Ashish Sabadra reiterates S&P Global (NYSE:SPGI) with a Outperform and maintains $434 price target.
RBC Capital Reiterates Outperform on CenterPoint Energy, Maintains $33 Price Target
RBC Capital analyst Shelby Tucker reiterates CenterPoint Energy (NYSE:CNP) with a Outperform and maintains $33 price target.
RBC Capital Reiterates Outperform on G Mining Ven, Maintains C$2 Price Target
RBC Capital analyst Michael Siperco reiterates G Mining Ven (TSXV:GMIN) with a Outperform and maintains C$2 price target.
Mizuho Reiterates Buy on Oracle, Maintains $116 Price Target
Mizuho analyst Siti Panigrahi reiterates Oracle (NYSE:ORCL) with a Buy and maintains $116 price target.
Credit Suisse Reiterates Outperform on Dell Technologies, Maintains $50 Price Target
Credit Suisse analyst Anthony Crowdell reiterates Dell Technologies (NYSE:DELL) with a Outperform and maintains $50 price target.
Oppenheimer Reiterates Outperform on BioLife Solns, Maintains $28 Price Target
Oppenheimer analyst Suraj Kalia reiterates BioLife Solns (NASDAQ:BLFS) with a Outperform and maintains $28 price target.
Needham Reiterates Buy on Extreme Networks, Maintains $23.5 Price Target
Needham analyst Alex Henderson reiterates Extreme Networks (NASDAQ:EXTR) with a Buy and maintains $23.5 price target.
HC Wainwright & Co. Reiterates Buy on Jazz Pharmaceuticals, Maintains $204 Price Target
HC Wainwright & Co. analyst Oren Livnat reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and maintains $204 price target.
HC Wainwright & Co. Reiterates Buy on Keros Therapeutics, Maintains $100 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Keros Therapeutics (NASDAQ:KROS) with a Buy and maintains $100 price target.